国: アイルランド
言語: 英語
ソース: HPRA (Health Products Regulatory Authority)
HUMAN INSULIN (RECOMBINANT DNA ORIGIN)
Eli Lilly and Company Limited
A10AD01
HUMAN INSULIN (RECOMBINANT DNA ORIGIN)
100 IU/ML
Suspension for Injection
Subcutaneous administration
Pack size of 5
Product subject to prescription which may be renewed (B)
Lilly France
Humulin M3
Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis
Authorised
2015-03-13
1 PACKAGE LEAFLET: INFORMATION FOR THE USER HUMULIN M3 (MIXTURE 3) 100 IU/ML SUSPENSION FOR INJECTION IN CARTRIDGE (Insulin human) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Humulin M3 is and what it is used for 2. What you need to know before you use Humulin M3 3. How to use Humulin M3 4. Possible side effects 5. How to store Humulin M3 6. Contents of the pack and other information 1. WHAT HUMULIN M3 IS AND WHAT IT IS USED FOR Humulin M3 contains the active substance human insulin, which is used to treat diabetes. You get diabetes if your pancreas does not make enough insulin to control the level of glucose in your blood (blood sugar). Humulin M3 is used to control glucose in the long term. It is a premixed suspension of rapid and long acting insulin. Its action is prolonged by the inclusion of protamine sulfate in the suspension. Your doctor may tell you to use Humulin M3 as well as a longer-acting insulin. Each kind of insulin comes with its own patient information leaflet to tell you about it. Do not change your insulin unless your doctor tells you to. Be very careful if you do change insulin. Each type of insulin has a different colour and symbol on the pack and the cartridge so that you can easily tell the difference. 2. 完全なドキュメントを読む
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in cartridge 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 IU insulin human (produced in _E. coli _by recombinant DNA technology). One cartridge contains 3 ml equivalent to 300 IU of biphasic isophane insulin – 30 % soluble insulin / 70 % isophane insulin. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM A suspension for injection in a cartridge. Humulin M3 is a sterile suspension of human insulin in the proportion of 30 % soluble insulin to 70 % isophane insulin. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dosage should be determined by the physician, according to the requirement of the patient. _Paediatric population_ No data are available. Method of administration Humulin M3 should be given by subcutaneous injection but may although not recommended, also be given by intramuscular injection. This formulation should not be administered intravenously. Subcutaneous administration should be in the upper arms, thighs, buttocks or abdomen. Use of injection sites should be rotated so that the same site is not used more than approximately once a month. Care should be taken when injecting any Humulin insulin preparations to ensure that a blood vessel has not been entered. After any insulin injection, the injection site should not be massaged. Patients must be educated to use proper injection techniques. Humulin Mixture formulation is a ready-made defined mixture of soluble and isophane insulin designed to avoid the need for the patient to 完全なドキュメントを読む